Study explains control of cell metabolism in
Researchers identify a control mechanism for glutamine uptake in breast cancer cells and its importance for response to select chemotherapies.
2015-03-10
(Press-News.org) La Jolla, Calif., March 9, 2015 - Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do not. The findings highlight the level of glutamine, an essential nutrient for cancer development, as a determinant of breast cancer response to select anticancer therapies, and identify a marker associated with glutamine uptake, for potential prognosis and stratification of breast cancer therapy.
"Our study indicates that a protein called RNF5 determines breast cancer response to paclitaxel, one of the most common chemotherapy drugs," said Ze'ev Ronai, Ph.D., scientific director of Sanford-Burnham's La Jolla campus. "Paclitaxel belongs to a class of drugs called taxanes that work by triggering a stress response in cells that in turn promotes an interaction between RNF5 and glutamine uptake proteins. We found that this interaction causes degradation of the glutamine carrier proteins, leading to an insufficient supply of glutamine and the sensitization of breast cancer tumors to death."
The study results were published in today's online edition of Cancer Cell.
For some time researchers have known that many tumor cell types are dependent on glutamine for growth and survival, but didn't know how glutamine uptake was regulated. The new findings demonstrate the importance of RNF5 in the control of glutamine uptake, and in antagonizing tumor development. The findings also suggest that testing tumors for RNF5 and glutamine carrier protein levels, such as SLC1A5, may be used to identify patients best suited to taxanes-based therapy.
"Not all tumors are equipped to respond to paclitaxel therapy," said Ronai. "Using a cohort of more than 500 breast cancer patient samples, we found that only 30 percent of tumors exhibit high levels of RNF5 and low levels of glutamine carrier proteins--the optimal profile for response to paclitaxel."
"Understanding these types of cell mechanisms and tumor characteristics that determine the response to anticancer drugs can lead to better patient stratification as well as improved therapy approaches," said Gordon Mills, M.D., Ph.D., chairman of the Department of Systems Biology at MD Anderson Cancer Center, 2013 recipient of the Susan B. Komen Brinker Award for contributions to breast cancer research, and co-author of the study. "The opportunity to identify and target key pathways involved in the behavior of breast cancer cells has the potential to both increase efficacy and decrease toxicity of therapy."
"We also used this patient cohort to test the predictive value of measuring levels of glutamine carrier proteins as a prognostic marker," said Ronai. Our results indicate that these proteins are an outstanding marker of patient outcome, as good as currently used markers."
"We have started screening for inhibitors of glutamine carrier proteins as a potential new target for breast cancer treatment," said Ronai, who is also examining the mechanism for glutamine control in other tumor types.
INFORMATION:
The study was performed in collaboration with the Departments of Pathology, Yale University; the Department of Pathology, UC Davis and the Department of Systems Biology, MD Anderson Cancer Center.
This study was funded by NIH grants CA097105, CA128814, and P30 CA30199.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center, its NIH-designated Neuroscience Center Cores, and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at sanfordburnham.org.
Sanford-Burnham can also be found on Facebook at facebook.com/sanfordburnham and on Twitter @sanfordburnham.
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-10
McGill researchers have discovered, for the first time, the importance of a key epigenetic regulator in the development of the hippocampus, a part of the brain associated with learning, memory and neural stem cells. Epigenetic regulators change the way specific genes function without altering their DNA sequence. By working with mutant mice as models, the research team, led by Prof. Xiang-Jiao Yang, of McGill's Goodman Cancer Center & Department of Medicine, McGill University Health Center, was able to link the importance of a specific epigenetic regulator known as BRPF1 ...
2015-03-10
The combination of stress and heavy depression can significantly increase heart patient's risk of death or heart attack, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
The study examined the effect of high stress levels and high depressive symptoms among nearly 5,000 heart patients. Researchers concluded that risk is amplified when both conditions are present, thus validating the concept of a "psychosocial perfect storm."
"The increase in risk accompanying high stress and high depressive symptoms ...
2015-03-10
A review of nutrition and weight-loss interventions for people with impaired mobility found strategies are sorely lacking for people with neurological disabilities, according to a team of researchers from Case Western Reserve University and Cleveland Clinic.
Interventions are overwhelmingly geared toward muscular disorders, leaving a gap in approaches that could help people with neurological disabilities become more active, eat healthier and lose weight, they conclude.
The researchers wanted to learn more about interventions for people who, because of limited mobility, ...
2015-03-10
Identifying loss of dignity and lack of respectful treatment as preventable harms in health care, researchers at Johns Hopkins have taken on the ambitious task of defining and ensuring respectful care in the high-stakes environment of the intensive care unit (ICU). Their novel, multi-method approach is presented in a dedicated supplement to the journal Narrative Inquiry in Bioethics.
"In health care the importance of respect and dignity is often invoked, but has not been clearly defined in regard to treatment in the ICU," says Jeremy Sugarman, the Harvey M. Meyerhoff ...
2015-03-10
MOUNTAIN VIEW, Calif., March 10, 2015 -- Today marked the publication of the first ever genome-wide association study of rosacea, a common and incurable skin disorder. Led by Dr. Anne Lynn S. Chang of Stanford University's School of Medicine, and co-authored by 23andMe, the study is the first to identify genetic factors for this condition.
Rosacea (pronounced roh-ZAY-sha) is estimated to affect more than 16 million people in the United States alone1. Symptoms typically include redness, visible blood vessels, and pimple-like sores on the skin of the central face, and ...
2015-03-10
ANN ARBOR--Each year, millions of people lose billions of dollars in NCAA March Madness basketball pools. Still, most return the following year for another pummeling.
But flipping a coin yields better results than carefully selecting brackets, says Dae Hee Kwak, assistant professor of sport management at the University of Michigan School of Kinesiology.
"I completed my own (informal) bracket alongside our study by literally flipping a coin 63 times," Kwak said. "I wanted to see if this outperformed the hard thought-out selections made by the study participants in ...
2015-03-10
The sugar industry used several tactics to influence the setting of research priorities for the 1971 US National Caries Program (NCP), according to a study published by Cristin Kearns, Stanton Glantz and Laura Schmidt from the University of California San Francisco, US, in this week's PLOS Medicine.
The researchers analyzed an archive of 319 internal sugar industry documents from 1959 to 1971 (the "Roger Adams papers") and US National Institute of Dental Research (NIDR) documents to explore how the sugar industry sought to influence the setting of research priorities ...
2015-03-10
A newly discovered cache of industry documents reveals that the sugar industry worked closely with the National Institutes of Health in the 1960s and '70s to develop a federal research program focused on approaches other than sugar reduction to prevent tooth decay in American children.
An analysis of those papers by researchers at UC San Francisco appears March 10, 2015 in the open-source scientific journal, PLOS Medicine.
The archive of 319 industry documents, which were uncovered in a public collection at the University of Illinois, revealed that a sugar industry ...
2015-03-10
A new technique for creating artificial DNA that is faster, more accurate and more flexible than existing methods has been developed by scientists at Imperial College London.
The new system - called BASIC - is a major advance for the field of synthetic biology, which designs and builds organisms able to make useful products such as medicines, energy, food, materials and chemicals.
To engineer new organisms, scientists build artificial genes from individual molecules and then put these together to create larger genetic constructs which, when inserted into a cell, will ...
2015-03-10
Most military battlefield casualties die before reaching a surgical hospital. Of those soldiers who might potentially survive, most die from uncontrolled bleeding.
In some cases, there's not much medics can do -- a tourniquet won't stop bleeding from a chest wound, and clotting treatments that require refrigerated or frozen blood products aren't always available in the field.
That's why University of Washington researchers have developed a new injectable polymer that strengthens blood clots, called PolySTAT. Administered in a simple shot, the polymer finds any unseen ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study explains control of cell metabolism in
Researchers identify a control mechanism for glutamine uptake in breast cancer cells and its importance for response to select chemotherapies.
